91AV

Important update on event submissions and edits 01-May-2024
We are currently transitioning to a new RSC events submission system and website.
• New event submissions may take up to one week to be published while we complete the transition.
• Editing existing events is temporarily unavailable. New edit links will be issued next week.
Your patience is appreciated while we finalise these improvements to the RSC events website.
If you have any questions, please contact the Events Database Team eventsdatabase@rsc.org

EFMC-ACSMEDI Medicinal 91AV Frontiers 2026

22 June 2026 17:00 - 25 June 2026 13:00, Dublin, Ireland


Introduction
The EFMC-ACSMEDI Medicinal 91AV Frontiers is co-organised by EFMC (European Federation for Medicinal chemistry and Chemical biology) and ACS MEDI (Division of Medicinal 91AV of the American Chemical Society). The 2026 edition will be organised in Dublin, Ireland.

The 2026 programme will include:
- 3 high quality plenary lectures
- 9 sessions on key topics in Medicinal 91AV
- About 18 oral communications selected from the submitted abstracts
- An extensive social program to maximize your networking opportunities
- A poster session and a commercial exhibition

ACSMEDI-EFMC Medicinal 91AV Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.

The 2026 edition is chaired by Prof. Marina RUBINI (University College Dublin, Dublin , Ireland)
We look forward to meeting you in Dublin! 

The Organising Committee
Venue
Trinity Conference Centre

Arts and Humanities Building, Trinity Conference Centre, College Green, Dublin, 2, Ireland

Committee
Organised by
EFMC & ACSMEDI
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*